Preclinical Tomography System Market Size, Share, Growth, and Industry Analysis, By Type (CT, PET, SPECT, Composite System), By Application (Biopharmaceuticals, Research Institute, and Others), Regional Forecast (2022-2028)

REPORT OVERVIEW

• 
• Request Free Sample PDF to learn more about this report

The global preclinical tomography system market size was USD 416.7 million in 2021. The global COVID-19 pandemic was unprecedented & staggering, with preclinical tomography systems experiencing lower-than-anticipated demand across all regions compared to pre-pandemic times. Per our market research, the market is expected to touch USD 699.4 million by 2028, exhibiting a CAGR of 7.7% during the forecast period. The sudden spike in CAGR can be attributed to demand returning to pre-pandemic levels post the pandemic.

Neurological disorders, cancers, cardiovascular diseases, and autoimmune diseases are acute diseases targeted with preclinical imaging. The preclinical tomography system industry offers aid in visualizing living animals through high-resolution, 3D image generation for research, disease diagnosis, and drug development. The technological advancements in preclinical tomography have enabled the study of diseases at the molecular level, further aiding the fast transfer of preclinical studies from animal models to clinical investigations of humans. The demand for the product is set to rise in the forecast period owing to these factors and technological innovations.

The market is divided into application and type segments. The type segment consists of CT, PET SPECT, and composite systems, whereas the application segment consists of biopharmaceuticals and research institute uses. Cancer accounts for the most frequent usage of preclinical imaging, followed by neurological disorders and autoimmune diseases. The introduction of next-generation SPECT cameras with detectors can lower the radiation dose and shorten the diagnosis time, fueling the demand for preclinical tomography systems over the forecast period.

COVID-19 Impact: Closure of R&D Impeded Market Launches and Innovations

The closure of research and development activities owing to lockdowns and the pandemic severely affected the new market launches and innovations in the medical sector. With attention focused on developing a COVID-19 vaccine, researchers diverted their resources to other research activities during the last two years, negatively affecting product sales. Furthermore, the supply chain disruptions caused due to untimely closure of manufacturing activities also restrained and hampered market growth massively, leading to revenue and profit losses for investors and manufacturers worldwide. 

LATEST TRENDS

"Growth in R&D Activities to Propel Market Share"

The rising number of contract research projects and experiments by medical device manufacturers, robust research and development infrastructure, and increasing drug development activities will drive market growth during the forecast period. The increase of research and development activities is due to the full-scale resumption of research studies on diseases that treat preclinical tomography systems. Thus, the market is set to experience an exponential boom in production and demand post the pandemic.

RESTRAINING FACTORS

"High Costs of Installations and Operations to Hamper Market Growth"

The high installation and operational costs for functioning preclinical tomography systems in the medical industry will hamper the market growth after losses endured during the pandemic. The supply chain disruption in the industry and rising inflation due to ongoing tensions in Europe will restrain the market growth and impede profits and revenues of leading industrial players and worldwide investors. The growing raw material prices and the high demand for research activities in the field are also factors that will hamper the market growth.

SEGMENTATION

• 
• Request Free Sample PDF to learn more about this report

• By Type

The market is subcategorized based on types into CT, PET SPECT, and composite systems.

• By Application

The market is subcategorized based on applications in biopharmaceuticals, research institutes, and other sectors.

DRIVING FACTORS

"Technological Innovations to Lead Market Growth and Manufacturing"

Technological innovations in fields such as molecular imaging, growing demand for non-invasive animal imaging techniques, and surging awareness about the ill effects of radiation-based imaging will boost the preclinical tomography system market growth. The rise in the prevalence of several diseases in developed countries post the pandemic has prompted research studies being conducted worldwide. Therefore, the market will see an exponential boom in product demand during the forecast period.

"Government Initiatives and Funding to Support Market Growth"

The rising number of government initiatives and public-private partnership funding will support preclinical research and fuel the growth of the preclinical tomography system industry in the biopharmaceuticals and medical market. Developing regions such as the Asia Pacific will benefit from this development as countries in the area will be supported by leading industrial players to conduct research in their respective fields. Hence, the market revenues and shares of worldwide players and investors will see massive growth.

REGIONAL INSIGHTS

• 
• Request Free Sample PDF to learn more about this report

"North America to Lead Market Share Owing to Rise in R&D Activities"

The North American region will lead the preclinical tomography system market share owing to a rise in research and development activities to study the growth trajectory of diseases such as cancer and autoimmune diseases in the region. The demand for the system has increased with the prevalence of neurological & cardiovascular diseases amongst the population in the American region post the pandemic. Therefore, the rising number of studies in the medical field coupled with the growing number of conditions will lead to regional market share and growth.

KEY INDUSTRIAL PLAYERS

"Market Players to Boost Market Growth"

The report analyzes various market players in the industry, and the information is published after research, analysis of trends, key industry developments, initiatives, and technological developments and innovations. The report also includes research on companies, technical and environmental outcomes, and newly emerging industries' impact and risks. The study considers all the points after a comprehensive analysis, thus generating future possibilities for the market. Therefore, the factors mentioned in the report are subject to change as the dynamics and situation of the market change. North America will lead the market share, with the U.S. leading the market growth.

List of Market Players Profiled

• Bruker (U.S.)
• MR Solutions (U.K.)
• Scanco Medical (Switzerland)
• PerkinElmer (U.S.)
• Trifoil Imaging (U.S.)
• Mediso (Budapest)
• Sedecal (Spain)
• MILabs (Netherlands)

INDUSTRY DEVELOPMENT

• August 2022: The U.S.-based clinical equipment company Bruker has announced new scientific innovations in biology and pathobiology research with the introduction of NMR technology that will facilitate cell biology research for scientists in the field of cancer. This development will drive market growth, share, and revenue, enabling manufacturers and investors to earn more profits. The market will continue to see innovations under the leadership of Bruker, thus expanding the worldwide scope of the product.

REPORT COVERAGE

The report examines elements that affect the demand & supply and estimates dynamic forces for the forecasted period. After evaluating the market factors, the report provides an extensive, comprehensive SWOT analysis. The information estimates the factors mentioned, taken into consideration after thorough research. The report also includes information on segmentation, market trends and the latest worldwide developments, key industry mergers and acquisitions, and an analysis of the risks of the preclinical tomography systems. The report lists the leading industrial players worldwide and the regions that will experience growth during the forecast period.